Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ProFEIBA: FEIBA Prophylaxis in Hemophilia A with Inhibitors
NCT00221195Phase 3Completed
- Sponsor
- Tulane University
- Start
- Jun 2003
- Primary completion
- Dec 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of anti-inhibitor coagulant complex in hemophilia A, sponsored by Tulane University. Started Jun 2003; status: completed.
02
Drugs
anti-inhibitor coagulant complex
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT00221195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00221195.